#USA #New York #Telehealth #GLP-1 Medications #CoreAge Rx

CoreAge Rx Announced GLP-1 Medication Price Reductions

CoreAge Rx, a prominent telehealth company focused on weight management, has publicly announced a significant reduction in the cost of its GLP-1 program. Effective immediately, compounded semaglutide is now available monthly for as low as $79, while compounded tirzepatide is priced at $129 per month with an annual prepayment option. These changes mark a drop from the previously announced prices of $99 and $149, respectively, earlier this year.

The modification in pricing continues with the flat-rate structure that CoreAge Rx originally introduced to simplify cost expectations for patients seeking weight management treatments. This pricing structure includes comprehensive services: a provider consultation, medications at all dosage levels, and expedited overnight cold shipping—all included in one upfront payment without any hidden membership fees.

Ella Jones, a spokesperson from CoreAge Rx, underscores the motivation behind the new pricing strategy. She states, “When we launched flat-rate pricing, our aim was to remove the uncertainty around treatment costs. Now, we're taking further action by reducing the price itself. Patients will still pay one flat rate, regardless of whether they are beginning treatment or on maintained dosages, which is now $20 less each month.”

Patients interested in the program start with a free online consultation. During this process, a U.S.-licensed healthcare provider reviews each individual’s medical history. Should it be deemed appropriate, a prescription is issued and filled through a state board-regulated 503A compounding pharmacy, which specializes in tailored medication delivery. Typically, patients receive their medications within three to five business days after approval, thanks to the swift, secure cold shipping arrangements CoreAge Rx follows.

The GLP-1 program offers two options: semaglutide, which acts as a GLP-1 receptor agonist, and tirzepatide, which targets both GLP-1 and GIP receptors. A licensed provider assists each patient in selecting the right medication option based on their unique health needs and weight management goals, further emphasizing CoreAge Rx’s commitment to personalized care.

Jones notes, “Cost is often a significant barrier that prevents individuals from pursuing or maintaining weight management care. By offering lower, predictable pricing alongside a fully online procedure, we are creating a more accessible entry point for patients considering treatment.”

For those seeking more information or wishing to commence their free online consultation, visit https://www.coreagerx.com/.

About CoreAge Rx

CoreAge Rx is dedicated to providing innovative telehealth solutions tailored for effective weight management. The company connects patients to U.S.-licensed healthcare professionals via an online platform, facilitating quick access to prescribed medications without the burden of unpredictable costs or hidden fees. While medication is compounded to provide customized treatments, patients are advised that compounded medications have not undergone FDA approval for safety, effectiveness, or quality. All prescriptions are issued only when medically necessary, ensuring that patient safety remains a paramount concern.

It's important to acknowledge that GLP-1 medications can lead to side effects, including nausea, vomiting, and diarrhea, and may not be suitable for every patient. Pricing may reflect annual prepayments, which could differ from monthly payment structures.

Conclusion

As CoreAge Rx progresses in its mission to enhance access to weight management treatments, the company is making noteworthy strides in reducing prices and easing the treatment process for patients. This helps pave the way for more individuals to make positive lifestyle changes without the financial burden previously associated with such medications.